COMMUNIQUÉS West-GlobeNewswire

Picard Announces Appointment of Two New Members to its Board of Directors
10/09/2025
Appointments strengthen Picard’s Board with proven expertise in capital markets and global MedTech leadership TUCSON, Ariz., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the [...]
Major shareholder announcement
10/09/2025
Please read the full announcement in PDF Attachments Novozymes B 04 September 2025_Final 2025_44_Major_Shareholders_Announcement
FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies
10/09/2025
Pilot studies have shown encouraging results that are supporting the company’s pre-IND enabling development, marking a critical step toward clinical translation of the Bone Marrow Organoid technology HOUSTON, Sept. 10, [...]
Ernexa Therapeutics Provides Update on Operational Excellence and Performance
10/09/2025
The company’s operating loss declined by 51% year-over-year, reflecting a laser focus on relentless execution and significant progress in expense reduction CAMBRIDGE, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ernexa [...]
Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms
10/09/2025
SOLANA BEACH, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
10/09/2025
CHICAGO and FORT WORTH, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for [...]
Wellcome Leap and Pivotal Commit $100 Million to Women’s Health Research to Deliver Breakthroughs in Years, Not Decades
10/09/2025
Partnership brings Leap’s total investment to a quarter billion dollars – advancing toward a $1 billion goal to transform outcomes for women worldwide SAN DIEGO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Wellcome Leap, a U.S. [...]
Eleos Launches Smarter Support for Group Therapy and SUD Care
10/09/2025
New Groups capability represents the first AI solution to deliver individual speaker summaries for group therapy sessions, enabling SUD organizations to achieve documentation compliance at scale Eleos to unveil product [...]
neurocare group's Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression
10/09/2025
Munich, Germany; Atlanta, Georgia - September 10, 2025 – neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health and performance, today announced it has received FDA [...]
Saudi Food and Drug Authority, AAMI Partner on Medtech Best Practices
10/09/2025
SFDA and AAMI Sign Memorandum of Understanding Arlington, Virginia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Association for the Advancement of Medical Instrumentation (AAMI) has signed a memorandum of understanding with [...]
KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025
10/09/2025
RIYADH, Saudi Arabia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) led Saudi healthcare institutions in clinical trials, conducting 48% of all clinical trials [...]
NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program
10/09/2025
The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to start the IND-enabling program for the NN-840 program with an IND submission expected next year This NIH grant award strongly confirms the scientific and [...]
Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions
10/09/2025
SHANGHAI, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, signed a strategic partnership with Innovent Biologics to [...]
Les données publiées dans The New England Journal of Medicine démontrent que l’association de RYBREVANT®▼ (amivantamab) et de LAZCLUZE®▼ (lazertinib) serait susceptible de redéfinir les perspectives de survie dans le traitement de première
10/09/2025
Ce schéma thérapeutique combiné sans chimiothérapie pourrait ouvrir une nouvelle ère dans le traitement de première intention, avec une survie globale médiane prévue supérieure à quatre ans, dépassant ainsi de plus d’un [...]
Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation
10/09/2025
STAFFORD, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia
10/09/2025
BXCL501 demonstrated a significant mean reduction in mCGI-S score from baseline compared to placebo at 2 hours across 2,433 treated episodes (p<.05) Complete resolution of agitation was significantly higher with [...]
Purespring Therapeutics to Participate in the 2025 BofA Healthcare Trailblazers Private Company Conference
10/09/2025
London – 10 September 2025 - Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, today announced that members of its management team will participate in the [...]
Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)
10/09/2025
ORR of 35% in previously treated squamous NSCLC patients with responses across PD-L1 TPS scores Differentiated structure of ‘2510 potentially results in best-in-class monotherapy activity in 2L+ NSCLC for PD-(L)1xVEGF [...]
OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System
10/09/2025
WARSAW, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]

Pages